Cargando…
A case report of targeted therapy with apatinib in a patient with advanced gastric cancer and high serum level of alpha-fetoprotein
BACKGROUND: Alpha-fetoprotein (AFP) is an important marker for hepatocellular carcinoma, and the detection of serum AFP is currently the principle method for the diagnosis of hepatocellular carcinoma. The prevalence of gastric cancer (GC) with high level of serum AFP is extremely rare, but has uniqu...
Autores principales: | Zhu, Xue-Ru, Zhu, Mei-Ling, Wang, Qing, Xue, Wen-Ji, Wang, Yi-Wei, Wang, Rui-Fen, Chen, Si-Yu, Zheng, Lei-Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402553/ https://www.ncbi.nlm.nih.gov/pubmed/27631210 http://dx.doi.org/10.1097/MD.0000000000004610 |
Ejemplares similares
-
Dynamic Change in Serum Alpha-fetoprotein Level Predicts Treatment Response and Prognosis of Alpha-fetoprotein-producing Gastric Cancer
por: Wang, Ruhan, et al.
Publicado: (2020) -
Apatinib combined with S-1 as second-line therapy in advanced gastric cancer
por: Qiu, Zhi-Yuan, et al.
Publicado: (2021) -
Male mammary gland development after apatinib therapy in advanced gastric cancer: A case report
por: Hui, Yan, et al.
Publicado: (2020) -
Apatinib concurrent gemcitabine for controlling malignant ascites in advanced pancreatic cancer patient: A case report
por: Liang, Lijun, et al.
Publicado: (2017) -
A Case Report of Gastrointestinal Hemorrhage and Perforation During Apatinib Treatment of Gastric Cancer
por: Li, Xiao-Fen, et al.
Publicado: (2015)